Global Heart Failure Diagnostics to Grow owing to Increasing Prevalent Cases of HF in Aging Population


Published Date : Jun 20, 2016

ALBANY, NY, June 20, 2016 - MarketResearchReports.biz has recently added a new report, titled ‘EpiCast Report: Heart Failure - Epidemiology Forecast To 2025,’ to their offering. In the 7MM (Germany, the U.S, France, the U.K., Italy, Spain, and Japan), the diagnosed incident heart failure cases are expected to increase from 1,094,344 in 2015 to 1,400,377 by 2025, progressing at a 2.80% AGR from 2015 to 2025. 

As per the findings of the report, the United States is expected to have the maximum number of diagnosed incident heart failure (HF) cases and diagnosed prevalent heart failure cases. By 2025, the U.S. is expected to have 1,052,831 incident cases of heart failure and 6,170,142 prevalent cases of chronic heart failure diagnosed.

In 2015 in the 7MM, there were 13,756,453 diagnosed prevalent heart failure cases. The epidemiologists anticipated that the global diagnosed prevalent heart failure cases would reach 16,105,489 by 2025, at an average 1.71% AGR for the period from 2015 to 2025. The New York Heart Association (NYHA) classifies heart failure cases under Class I, Class II, Class III, and Class IV. In 2015 in the 7MM, 37.59% of prevalent cases of chronic heart failure were diagnosed in NYHA Class I whereas there were 39.54% cases in Class II. Approximate 19.11% diagnosed cases were in Class III and 3.75% in Class IV. 

Heart failure, a heterogeneous condition restricts the heart to pump sufficient amount of blood. This results in shortness of breath, fatigue, and coughing. As per the American Heart Association, heart failure is a complex clinical condition that results in functional or structural cardiac disorder. The number of people suffering from acute heart failure and chronic heart failure is increasing at a rapid pace. Heart failure is a common syndrome in people aged 50 years and above. The rising aging population has also led to the increasing occurrence of heart failures.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/728956

Leading players are constantly enhancing their treatments and therapies for heart failure. Over the past few years, there have been many improvements in therapies used for treating heart failure. However, the patient mortality rate has remained high. This has made it essential to follow a procedure of early discovery of susceptible individuals to offer preventive measures. With many new companies introducing new therapies, the healthcare service providers will be able to diagnose acute and chronic heart failure cases in a better way.

Advancements in medical procedures, the constant introduction of highly advanced medical devices, and the increasing adoption of new therapies are some of the major factors supporting the diagnostics of heart failure cases.

For a better understanding, the analysts have segmented diagnosed incident cases and diagnosed prevalent cases of heart failure into sex and age. The diagnosed incident cases are sub-segmented into ejection fraction, acute heart failure hospitalization, readmissions, ventricular dysfunction, and hospital length.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz